Buprenorphine and Naloxone
These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE AND NALOXONE Sublingual Tablets for sublingual administration CIII Initial U.S. Approval: 2002
47236a95-ba0b-4f6a-b406-858cabc726df
HUMAN PRESCRIPTION DRUG LABEL
Dec 20, 2023
Akorn Operating Company LLC (dba Akorn)
DUNS: 117696873
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
buprenorphine hydrochloride and naloxone hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
buprenorphine hydrochloride and naloxone hydrochloride
Product Details
FDA regulatory identification and product classification information